Clinical Trial Update: Infusion Laboratory: Protocol 1 - Selegeline - 2 [Phase 1]

View source ↗

Summary

Phase 1 trial update for Selegiline (Infusion Laboratory Protocol 1) in cocaine use disorder has completed. Sponsor is the National Institute on Drug Abuse (NID…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• Selegiline (selegiline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: COMPLETED